Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax
Clinical trial NCT06090786 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06090786
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2027-07-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.